Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vasopressin in Hyperkinetic Septic Shock
NCT07052084Phase 3Recruiting
- Sponsor
- Assistance Publique-Hôpitaux de Marseille
- Start
- Mar 2026
- Primary completion
- Feb 2028
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of vasopressin in septic shock, sponsored by Assistance Publique-Hôpitaux de Marseille. Started Mar 2026; status: recruiting.
02
Drugs
vasopressin
03
Conditions
septic shock
Beyond the preview
Go deeper on NCT07052084.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07052084.